On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S. of a second point-of-care rapid test kit that can detect antibodies associated with COVID-19 in as few as 15 minutes.

The Company will work with Becton, Dickinson and BioMedomics, a privately held, North Carolina-based clinical diagnostics company.